Oxurion NV - ESG Rating & Company Profile powered by AI
This article includes a Q&A section about Oxurion NV. The report of Oxurion NV is prepared by All Street Sevva using leading artificial intelligence. If you are employed by Oxurion NV and you would like to licence your ESG rating, please get in touch.
Oxurion NV in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.0; made up of an environmental score of 5.3, social score of 1.6 and governance score of 2.0.
3.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1309 | Willow Biosciences Inc | 3.1 | Medium |
| 1309 | biOasis Technologies Inc | 3.1 | Medium |
| 1336 | Oxurion NV | 3.0 | Medium |
| 1336 | BridgeBio Pharma Inc | 3.0 | Medium |
| 1336 | Absci Corp | 3.0 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Oxurion NV have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Oxurion NV disclose current and historical energy intensity?
Sign up for free to unlockDoes Oxurion NV report the average age of the workforce?
Sign up for free to unlockDoes Oxurion NV reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Oxurion NV disclose its ethnicity pay gap?
Sign up for free to unlockDoes Oxurion NV disclose cybersecurity risks?
Sign up for free to unlockDoes Oxurion NV offer flexible work?
Sign up for free to unlockDoes Oxurion NV have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Oxurion NV disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Oxurion NV conduct supply chain audits?
Sign up for free to unlockDoes Oxurion NV disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Oxurion NV conduct 360 degree staff reviews?
Sign up for free to unlockDoes Oxurion NV disclose the individual responsible for D&I?
Sign up for free to unlockDoes Oxurion NV disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Oxurion NV disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Oxurion NV disclose water use targets?
Sign up for free to unlockDoes Oxurion NV have careers partnerships with academic institutions?
Sign up for free to unlockDid Oxurion NV have a product recall in the last two years?
Sign up for free to unlockDoes Oxurion NV disclose incidents of discrimination?
Sign up for free to unlockDoes Oxurion NV allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Oxurion NV issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Oxurion NV disclose parental leave metrics?
Sign up for free to unlockDoes Oxurion NV disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Oxurion NV disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Oxurion NV disclose the pay ratio of women to men?
Sign up for free to unlockDoes Oxurion NV support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Oxurion NV disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Oxurion NV reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Oxurion NV involved in embryonic stem cell research?
Sign up for free to unlockDoes Oxurion NV disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Oxurion NV disclose its waste policy?
Sign up for free to unlockDoes Oxurion NV report according to TCFD requirements?
Sign up for free to unlockDoes Oxurion NV disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Oxurion NV disclose energy use targets?
Sign up for free to unlockDoes Oxurion NV disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Oxurion NV have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Oxurion NV
These potential risks are based on the size, segment and geographies of the company.
Oxurion NV, a biopharmaceutical company, develops and commercializes medicines for the treatment of eye diseases in Belgium and internationally. Its lead product is JETREA for the treatment of vitreomacular adhesion/vitreomacular traction. The company also develops THR-149, a plasma kallikrein inhibitor, which is in Phase II clinical trials for the treatment of diabetic macular edema (DME); and THR-687, an integrin antagonist which is in Phase II clinical trials for the treatment of DME. It has collaboration agreements with Bicycle Therapeutics, INC Research, and Galapagos NV. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.